250 related articles for article (PubMed ID: 34018657)
1. Proteolysis Targeting Chimera (PROTAC) for Macrophage Migration Inhibitory Factor (MIF) Has Anti-Proliferative Activity in Lung Cancer Cells.
Xiao Z; Song S; Chen D; van Merkerk R; van der Wouden PE; Cool RH; Quax WJ; Poelarends GJ; Melgert BN; Dekker FJ
Angew Chem Int Ed Engl; 2021 Aug; 60(32):17514-17521. PubMed ID: 34018657
[TBL] [Abstract][Full Text] [Related]
2. Thieno[2,3-
Xiao Z; Osipyan A; Song S; Chen D; Schut RA; van Merkerk R; van der Wouden PE; Cool RH; Quax WJ; Melgert BN; Poelarends GJ; Dekker FJ
J Med Chem; 2022 Feb; 65(3):2059-2077. PubMed ID: 35041425
[TBL] [Abstract][Full Text] [Related]
3. Discovery of potent small molecule PROTACs targeting mutant EGFR.
Zhao HY; Yang XY; Lei H; Xi XX; Lu SM; Zhang JJ; Xin M; Zhang SQ
Eur J Med Chem; 2020 Dec; 208():112781. PubMed ID: 32883633
[TBL] [Abstract][Full Text] [Related]
4. Design and Synthesis of EZH2-Based PROTACs to Degrade the PRC2 Complex for Targeting the Noncatalytic Activity of EZH2.
Liu Z; Hu X; Wang Q; Wu X; Zhang Q; Wei W; Su X; He H; Zhou S; Hu R; Ye T; Zhu Y; Wang N; Yu L
J Med Chem; 2021 Mar; 64(5):2829-2848. PubMed ID: 33606537
[TBL] [Abstract][Full Text] [Related]
5. P115 promotes growth of gastric cancer through interaction with macrophage migration inhibitory factor.
Li XJ; Luo Y; Yi YF
World J Gastroenterol; 2013 Dec; 19(46):8619-29. PubMed ID: 24379579
[TBL] [Abstract][Full Text] [Related]
6. Macrophage migration inhibitory factor promotes osteosarcoma growth and lung metastasis through activating the RAS/MAPK pathway.
Wang C; Zhou X; Li W; Li M; Tu T; Ba X; Wu Y; Huang Z; Fan G; Zhou G; Wu S; Zhao J; Zhang J; Chen J
Cancer Lett; 2017 Sep; 403():271-279. PubMed ID: 28642171
[TBL] [Abstract][Full Text] [Related]
7. Interaction of macrophage migration inhibitory factor with ceruloplasmin: role of labile copper ions.
Kostevich VA; Sokolov AV; Grudinina NA; Zakharova ET; Samygina VR; Vasilyev VB
Biometals; 2015 Oct; 28(5):817-26. PubMed ID: 26091949
[TBL] [Abstract][Full Text] [Related]
8. Discovery of Proteolysis-Targeting Chimera Molecules that Selectively Degrade the IRAK3 Pseudokinase.
Degorce SL; Tavana O; Banks E; Crafter C; Gingipalli L; Kouvchinov D; Mao Y; Pachl F; Solanki A; Valge-Archer V; Yang B; Edmondson SD
J Med Chem; 2020 Sep; 63(18):10460-10473. PubMed ID: 32803978
[TBL] [Abstract][Full Text] [Related]
9. Optimization of Pyrazoles as Phenol Surrogates to Yield Potent Inhibitors of Macrophage Migration Inhibitory Factor.
Trivedi-Parmar V; Robertson MJ; Cisneros JA; Krimmer SG; Jorgensen WL
ChemMedChem; 2018 Jun; 13(11):1092-1097. PubMed ID: 29575754
[TBL] [Abstract][Full Text] [Related]
10. Macrophage migration inhibitory factor (MIF) promotes rat airway muscle cell proliferation and migration mediated by ERK1/2 and FAK signaling.
Lan H; Wang N; Chen Y; Wang X; Gong Y; Qi X; Luo Y; Yao F
Cell Biol Int; 2018 Jan; 42(1):75-83. PubMed ID: 28851074
[TBL] [Abstract][Full Text] [Related]
11. The macrophage migration inhibitory factor MIF is a phenylpyruvate tautomerase.
Rosengren E; Aman P; Thelin S; Hansson C; Ahlfors S; Björk P; Jacobsson L; Rorsman H
FEBS Lett; 1997 Nov; 417(1):85-8. PubMed ID: 9395080
[TBL] [Abstract][Full Text] [Related]
12. Loss of macrophage migration inhibitory factor impairs the growth properties of human HeLa cervical cancer cells.
Xiao DZ; Dai B; Chen J; Luo Q; Liu XY; Lin QX; Li XH; Huang W; Yu XY
Cell Prolif; 2011 Dec; 44(6):582-90. PubMed ID: 21991924
[TBL] [Abstract][Full Text] [Related]
13. Macrophage migration inhibitory factor of the parasitic nematode Trichinella spiralis.
Tan TH; Edgerton SA; Kumari R; McAlister MS; Roe SM; Nagl S; Pearl LH; Selkirk ME; Bianco AE; Totty NF; Engwerda C; Gray CA; Meyer DJ
Biochem J; 2001 Jul; 357(Pt 2):373-83. PubMed ID: 11439086
[TBL] [Abstract][Full Text] [Related]
14. Structural Plasticity in the C-Terminal Region of Macrophage Migration Inhibitory Factor-2 Is Associated with an Induced Fit Mechanism for a Selective Inhibitor.
Pantouris G; Bucala R; Lolis EJ
Biochemistry; 2018 Jul; 57(26):3599-3605. PubMed ID: 29847104
[TBL] [Abstract][Full Text] [Related]
15. Macrophage migration inhibitory factor (MIF) enzymatic activity and lung cancer.
Mawhinney L; Armstrong ME; O' Reilly C; Bucala R; Leng L; Fingerle-Rowson G; Fayne D; Keane MP; Tynan A; Maher L; Cooke G; Lloyd D; Conroy H; Donnelly SC
Mol Med; 2015 Apr; 20(1):729-35. PubMed ID: 25826675
[TBL] [Abstract][Full Text] [Related]
16. Role of macrophage migration inhibitory factor in primary glioblastoma multiforme cells.
Baron N; Deuster O; Noelker C; Stüer C; Strik H; Schaller C; Dodel R; Meyer B; Bacher M
J Neurosci Res; 2011 May; 89(5):711-7. PubMed ID: 21360573
[TBL] [Abstract][Full Text] [Related]
17. Multiple binding modes of isothiocyanates that inhibit macrophage migration inhibitory factor.
Spencer ES; Dale EJ; Gommans AL; Rutledge MT; Vo CT; Nakatani Y; Gamble AB; Smith RA; Wilbanks SM; Hampton MB; Tyndall JD
Eur J Med Chem; 2015 Mar; 93():501-10. PubMed ID: 25743213
[TBL] [Abstract][Full Text] [Related]
18. Macrophage migration inhibitory factor engages PI3K/Akt signalling and is a prognostic factor in metastatic melanoma.
Oliveira CS; de Bock CE; Molloy TJ; Sadeqzadeh E; Geng XY; Hersey P; Zhang XD; Thorne RF
BMC Cancer; 2014 Aug; 14():630. PubMed ID: 25168062
[TBL] [Abstract][Full Text] [Related]
19. Discovery of potent epidermal growth factor receptor (EGFR) degraders by proteolysis targeting chimera (PROTAC).
Zhang H; Zhao HY; Xi XX; Liu YJ; Xin M; Mao S; Zhang JJ; Lu AX; Zhang SQ
Eur J Med Chem; 2020 Mar; 189():112061. PubMed ID: 31951960
[TBL] [Abstract][Full Text] [Related]
20. Anti-macrophage migration inhibitory factor (MIF) activity of ibudilast: A repurposing drug attenuates the pathophysiology of leptospirosis.
Sumaiya K; Selvambika P; Natarajaseenivasan K
Microb Pathog; 2022 Dec; 173(Pt A):105786. PubMed ID: 36150555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
